Treatment of breast cancer during pregnancy: an observational study.
Standard
Treatment of breast cancer during pregnancy: an observational study. / Loibl, Sibylle; Han, Sileny N; von Minckwitz, Gunter; Bontenbal, Marijke; Ring, Alistair; Giermek, Jerzy; Fehm, Tanja; Kristel, Van Calsteren; Linn, Sabine C; Schlehe, Bettina; Gziri, Mina Mhallem; Westenend, Pieter J; Müller, Volkmar; Heyns, Liesbeth; Rack, Brigitte; Ben, Van Calster; Harbeck, Nadia; Lenhard, Miriam; Halaska, Michael J; Kaufmann, Manfred; Nekljudova, Valentina; Amant, Frederic.
In: LANCET ONCOL, Vol. 13, No. 9, 9, 2012, p. 887-896.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Treatment of breast cancer during pregnancy: an observational study.
AU - Loibl, Sibylle
AU - Han, Sileny N
AU - von Minckwitz, Gunter
AU - Bontenbal, Marijke
AU - Ring, Alistair
AU - Giermek, Jerzy
AU - Fehm, Tanja
AU - Kristel, Van Calsteren
AU - Linn, Sabine C
AU - Schlehe, Bettina
AU - Gziri, Mina Mhallem
AU - Westenend, Pieter J
AU - Müller, Volkmar
AU - Heyns, Liesbeth
AU - Rack, Brigitte
AU - Ben, Van Calster
AU - Harbeck, Nadia
AU - Lenhard, Miriam
AU - Halaska, Michael J
AU - Kaufmann, Manfred
AU - Nekljudova, Valentina
AU - Amant, Frederic
PY - 2012
Y1 - 2012
N2 - Little is known about the treatment of breast cancer during pregnancy. We aimed to determine whether treatment for breast cancer during pregnancy is safe for both mother and child.
AB - Little is known about the treatment of breast cancer during pregnancy. We aimed to determine whether treatment for breast cancer during pregnancy is safe for both mother and child.
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Young Adult
KW - Multivariate Analysis
KW - Cohort Studies
KW - Europe
KW - Registries
KW - Lymphatic Metastasis
KW - Disease-Free Survival
KW - Incidence
KW - Retrospective Studies
KW - Infant, Newborn
KW - Neoplasm Staging
KW - Pregnancy
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Abnormalities, Drug-Induced/epidemiology
KW - Apgar Score
KW - Birth Weight/drug effects
KW - Breast Neoplasms/diagnosis/drug therapy/pathology/surgery
KW - Carcinoma, Ductal/diagnosis/drug therapy/pathology/secondary
KW - Carcinoma, Lobular/diagnosis/drug therapy/pathology/secondary/surgery
KW - Delivery, Obstetric/statistics & numerical data
KW - Infant, Newborn, Diseases/chemically induced/epidemiology
KW - Organ Preservation
KW - Pregnancy Complications, Neoplastic/drug therapy
KW - Pregnancy Outcome/epidemiology
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Young Adult
KW - Multivariate Analysis
KW - Cohort Studies
KW - Europe
KW - Registries
KW - Lymphatic Metastasis
KW - Disease-Free Survival
KW - Incidence
KW - Retrospective Studies
KW - Infant, Newborn
KW - Neoplasm Staging
KW - Pregnancy
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Abnormalities, Drug-Induced/epidemiology
KW - Apgar Score
KW - Birth Weight/drug effects
KW - Breast Neoplasms/diagnosis/drug therapy/pathology/surgery
KW - Carcinoma, Ductal/diagnosis/drug therapy/pathology/secondary
KW - Carcinoma, Lobular/diagnosis/drug therapy/pathology/secondary/surgery
KW - Delivery, Obstetric/statistics & numerical data
KW - Infant, Newborn, Diseases/chemically induced/epidemiology
KW - Organ Preservation
KW - Pregnancy Complications, Neoplastic/drug therapy
KW - Pregnancy Outcome/epidemiology
M3 - SCORING: Journal article
VL - 13
SP - 887
EP - 896
JO - LANCET ONCOL
JF - LANCET ONCOL
SN - 1470-2045
IS - 9
M1 - 9
ER -